Infinity Pharmaceuticals, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 30 rows in 2016. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2016-07-29: Reporting owner Tasker Seth A; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
- 2016-07-29: Reporting owner Tasker Seth A; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
- 2016-07-29: Reporting owner Tasker Seth A; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
- 2016-07-29: Reporting owner Tasker Seth A; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2016-07-29 holding as of filing | Tasker Seth A Officer (General Counsel) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $7.18 exercise price | 2016-07-29 | ||
| 2016-07-29 holding as of filing | Tasker Seth A Officer (General Counsel) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $6.25 exercise price | 2016-07-29 | ||
| 2016-07-29 holding as of filing | Tasker Seth A Officer (General Counsel) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $6.39 exercise price | 2016-07-29 | ||
| 2016-07-29 holding as of filing | Tasker Seth A Officer (General Counsel) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $5.94 exercise price | 2016-07-29 | ||
| 2016-07-29 holding as of filing | Tasker Seth A Officer (General Counsel) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $7.93 exercise price | 2016-07-29 | ||
| 2016-07-29 holding as of filing | Tasker Seth A Officer (General Counsel) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $16.57 exercise price | 2016-07-29 | ||
| 2016-07-29 holding as of filing | Tasker Seth A Officer (General Counsel) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $36.85 exercise price | 2016-07-29 | ||
| 2016-07-29 holding as of filing | Tasker Seth A Officer (General Counsel) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $45.24 exercise price | 2016-07-29 | ||
| 2016-07-29 holding as of filing | Tasker Seth A Officer (General Counsel) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $12.91 exercise price | 2016-07-29 | ||
| 2016-07-29 holding as of filing | Tasker Seth A Officer (General Counsel) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $11.24 exercise price | 2016-07-29 | ||
| 2016-07-29 holding as of filing | Tasker Seth A Officer (General Counsel) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $15.74 exercise price | 2016-07-29 | ||
| 2016-07-29 holding as of filing | Tasker Seth A Officer (General Counsel) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $16.53 exercise price | 2016-07-29 | ||
| 2016-07-29 holding as of filing | Tasker Seth A Officer (General Counsel) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $6.71 exercise price | 2016-07-29 | ||
| 2016-06-17 | Baselga Jose Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $1.52 exercise price | 2016-06-21 | |
| 2016-06-17 | SELBY NORMAN C Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $1.52 exercise price | 2016-06-21 | |
| 2016-06-17 | SELBY NORMAN C Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $1.52 exercise price | 2016-06-21 | |
| 2016-06-17 | SELBY NORMAN C Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,000 2,000 owned after | $1.52 exercise price | 2016-06-21 | |
| 2016-06-17 | SMITH IAN F Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $1.52 exercise price | 2016-06-21 | |
| 2016-06-17 | SMITH IAN F Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,000 4,000 owned after | $1.52 exercise price | 2016-06-21 | |
| 2016-06-17 | EVNIN ANTHONY B Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $1.52 exercise price | 2016-06-21 | |
| 2016-06-17 | EVNIN ANTHONY B Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,000 2,000 owned after | $1.52 exercise price | 2016-06-21 | |
| 2016-06-17 | VENUTI MICHAEL C Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $1.52 exercise price | 2016-06-21 | |
| 2016-06-17 | VENUTI MICHAEL C Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,000 4,000 owned after | $1.52 exercise price | 2016-06-21 | |
| 2016-06-17 | LANDER ERIC S Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $1.52 exercise price | 2016-06-21 | |
| 2016-06-17 | Berkowitz Jeffrey Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $1.52 exercise price | 2016-06-21 | |
| 2016-05-02 | Lindblom Christopher M Officer (Principal Accounting Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $5.87 exercise price | 2016-05-04 | |
| 2016-01-06 | BLOCH LAWRENCE E Officer (EVP, CFO & CBO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +70,000 70,000 owned after | $6.71 exercise price | 2016-01-08 | |
| 2016-01-06 | KANGO SUJAY Officer (Chief Commercial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +60,000 60,000 owned after | $6.71 exercise price | 2016-01-08 | |
| 2016-01-06 | ADAMS JULIAN Officer (President of R&D) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +80,000 80,000 owned after | $6.71 exercise price | 2016-01-08 | |
| 2016-01-06 | Perkins Adelene Q Director, Officer (President & CEO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +185,000 185,000 owned after | $6.71 exercise price | 2016-01-08 |